Answers are grounded in this paper and cite their sources.
Carbon monoxide (CO) is a promising therapeutic agent for aggressive triple‐negative breast cancer (TNBC) with limited effective treatments. Moreover, its precise and safe delivery to tumors remains a challenge. However, conventional CO‐releasing strategies present inefficient substrate supply and poor spatiotemporal control. Here, we report a bioinspired photocatalytic nanomachine (g‐C 3 N 4 ‐Au@Hb@MnCO 3 nanoparticles, CAHM NPs) with a “catalytic core–capture layer mineralization shell” architecture that integrates CO 2 generation, capture, and photocatalytic conversion with Mn 2+ ‐mediated immunomodulation for synergistic antitumor therapy. The system is constructed by immobilizing hemoglobin (Hb) on Au‐deposited graphitic carbon nitride (g‐C 3 N 4 ‐Au), followed by in situ mineralization of a pH‐responsive manganese carbonate (MnCO 3 ) shell. In the acidic tumor microenvironment, MnCO 3 decomposes to release CO 2 and Mn 2+ . The captured CO 2 is efficiently photoreduced to CO under 650 nm laser irradiation, inducing immunogenic cell death, while the released Mn 2+ activates the STING pathway to promote dendritic cell maturation and enhance antitumor immunity. In vitro and in vivo studies demonstrate that CAHM NPs in the Laser group effectively suppress tumor growth and elicit robust immune responses, with minimal toxicity. This work presents a novel strategy for spatially controlled CO therapy combined with STING activation, offering a promising platform for the treatment of TNBC.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: